Advancements in technology, such as genomic sequencing and artificial intelligence (AI), are revolutionizing cancer research. Genomic sequencing allows for personalized medicine approaches, tailoring treatments based on an individual's genetic makeup. AI can analyze vast datasets to identify patterns and predict outcomes, potentially leading to earlier diagnosis and more effective treatments. Institutions and companies at the forefront of these technologies frequently publish their findings in peer-reviewed journals and present at international conferences.
